Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: Monthly pen · hands-on product reveal. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
Stacking the claims as separate cards is a clean way to deliver several facts in ten seconds: what it is, what's new about it, what it costs relative to list, and how it compares. Each card is a short phrase, so the stack reads like a spec sheet the viewer can take in at a glance. The hand-held shot in natural light makes a medical product feel ordinary and approachable. The fine print spells out the half-price basis, the extra membership fee, and that full results are seen in about a year with ongoing use, per the ad.
Every card is about the product, and none names a problem the viewer has or a moment they'd recognize, so the ad speaks only to people already following GLP-1 news. Half the cost still has no dollar figure, which is the detail that would make the claim concrete. If you borrow the stacked-card format, make the top card your buyer's problem or the actual price, and let the product facts follow.
It identifies the product right away.
It gives the launch news and the price angle in quick succession.
It adds a comparison claim and carries the required disclosures.
Half the cost of the Zepbound autoinjector's list price when paying cash, with no insurance needed, per the on-screen text and fine print. An additional Ro membership fee applies, and no dollar amounts appear.
The ad sends people to Ro's weight-loss quiz entry, the destination for 71 of the 100 Ro ads in the Fluid library. A quiz sits on the strongest rung of the landing-page ladder, and this one starts fast: the page opens on "Lose weight on Ro," a banner claiming "The lowest prices for GLP-1s are on Ro," a photo of Serena Williams labeled as a Ro member, and a card asking "Which Ro option are you interested in?" with GLP-1 pill, GLP-1 shot, both, or a provider recommendation as the answers. The shot answer covers a pen ad, but the entry screen doesn't mention the new monthly pen or its price, so the launch news that earned the click doesn't carry through. A line about the new pen near the question card would let the page continue the story.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.